This Article Full Text Full Text (PDF) All Versions of this Article: 39/8/2370    most recent STROKEAHA.107.506824v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zhang, Y. Articles by Xu, Z. C. Search for Related Content PubMed PubMed Citation Articles by Zhang, Y. Articles by Xu, Z. C. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB GLUTAMIC ACID HYDROCHLORIDE Medline Plus Health Information Transient Ischemic Attack Related Collections Electrophysiology Animal models of human disease Brain Circulation and Metabolism

(Stroke. 2008;39:2370.)
© 2008 American Heart Association, Inc.

Original Contributions

Dopamine D1-Like Receptors Depress Excitatory Synaptic Transmissions in Striatal Neurons After Transient Forebrain Ischemia

Yuchun Zhang, PhD; Ping Deng, MD, PhD; Yiwen Ruan, MD, PhD Zao C. Xu, MD, PhD

From the Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis.

Correspondence to Zao C. Xu, MD, PhD, Department of Anatomy and Cell Biology, Indiana University School of Medicine, 635 Barnhill Dr, MS 507, Indianapolis, IN 46202.E-mail zxu{at}anatomy.iupui.edu

Background and Purpose— Spiny neurons in the neostriatum are highly vulnerable to ischemia. Despite an enormous body of research suggesting that dopamine is involved in ischemia-induced neuronal loss in the striatum, it remains unclear how dopamine interacts with the glutamatergic excitotoxicity that is widely accepted as a major cause of ischemic cell death. Our study was designed to investigate the effects of dopamine D1 receptor (D1R) activation on excitatory neurotransmission in postischemic striatal neurons.

Methods— We used the 4-vessel occlusion ischemia model and brain slice preparations. Whole-cell voltage-clamp recording was performed on striatal neurons to measure excitatory postsynaptic currents (EPSCs). Systemic administration of a D1R agonist after ischemia and hematoxylin/eosin staining were performed to evaluate the effects of D1R activation on ischemia-induced neuronal degeneration in the striatum.

Results— D1R activation depressed EPSCs in postischemic striatal neurons. The depression was attributable to inhibition of presynaptic release. An activator of cAMP-dependent protein kinase A (PKA) mimicked the depressive effects of D1R activation. Bath application of a PKA inhibitor blocked the depression of EPSCs, whereas intracellular postsynaptic application of the PKA inhibitor had no effect. The D1R agonist failed to reduce EPSC amplitude in the presence of an adenosine A1 receptor antagonist. Systemic administration of a D1R agonist after ischemia significantly attenuated ischemia-induced cell death in the striatum.

Conclusions— These results indicate that D1R activation presynaptically depresses excitatory synaptic transmission in striatal neurons after ischemia through activation of PKA and adenosine A1 receptors and thus demonstrate a novel mechanism of D1R-mediated protection against ischemia.

Key Words: dopamine • ischemia • striatum • excitatory postsynaptic currents • adenosine